CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS

Institutional investor · Portfolio as of Q1 2023

SEC EDGAR SourceSEC Filings

Top Holdings2,311 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

2.2M$858.8M3.8%$361.52+7.95%
18 qtrssince 2018-Q4
Increased
64

APPLE INC

5.1M$841M3.7%$123.49+31.39%
18 qtrssince 2018-Q4
Increased
61
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

8.8M$809.9M3.6%$77.88+1.03%
18 qtrssince 2018-Q4
Increased
77
VTVVTV
ETF

VANGUARD VALUE ETF

4.3M$590M2.6%$122.74+4.30%
18 qtrssince 2018-Q4
Increased
61

MICROSOFT CORP

1.8M$513.5M2.3%$196.83+41.30%
18 qtrssince 2018-Q4
Increased
56
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

8.7M$391.8M1.7%$38.57+5.92%
18 qtrssince 2018-Q4
Increased
60
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

948,541$388.3M1.7%$336.50+15.76%
18 qtrssince 2018-Q4
Increased
76
USMVUSMV
ETF

ISHARES EDGE MSCI MIN VOL US

5.1M$372.4M1.6%$64.62+6.25%
18 qtrssince 2018-Q4
Increased
53
IBTDIBTDDelisted
ETF

iShares iBonds Dec 2023 Term Tr

14.9M$369.2M1.6%$23.71+0.92%
3 qtrssince 2022-Q3
Increased
58
IBTFIBTFDelisted
ETF

ISHARES TR

15.7M$368.7M1.6%$20.67+1.31%
2 qtrssince 2022-Q4
Increased
59
IBTEIBTEDelisted
ETF

iShares iBonds Dec 2024 Term Tr

15.2M$364.3M1.6%$21.88+1.09%
2 qtrssince 2022-Q4
Increased
57
SHYSHY
ETF

ISHARES 1-3 YEAR TREASURY BO

3.5M$291.5M1.3%$72.49+0.11%
18 qtrssince 2018-Q4
Decreased
0
MTUMMTUM
ETF

ISHARES MSCI USA MOMENTUM FA

1.9M$266.1M1.2%$141.63-5.14%
12 qtrssince 2020-Q2
Increased
53

BERKSHIRE HATHAWAY INC-CL B

768,722$237.4M1.0%$265.18+15.04%
18 qtrssince 2018-Q4
Increased
54
XLKXLK
ETF

TECHNOLOGY SELECT SECTOR FUND SPDR

1.5M$227.7M1.0%$57.58+26.77%
18 qtrssince 2018-Q4
Increased
51
IEFIEF
ETF

ISHARES 7-10 YEAR TREASURY B

2.2M$221.4M1.0%$89.40-1.80%
18 qtrssince 2018-Q4
Decreased
0
VBVB
ETF

VANGUARD SMALL-CAP VIPERS

1.1M$201.5M0.9%$189.02-5.58%
18 qtrssince 2018-Q4
Increased
55
2.6M$198M0.9%
18 qtrssince 2018-Q4
Increased
44
USFRUSFR
ETF

WISDOMTREE TR

3.9M$194.7M0.9%$42.82+1.07%
5 qtrssince 2022-Q1
Increased
65

PROCTER & GAMBLE CO/THE

1.3M$192.9M0.8%$111.48+21.72%
18 qtrssince 2018-Q4
Increased
45
$22.8B
AUM
2,311
Positions
Q1 2023
Filing
Rating · 5.0
Quarterly Portfolio Change
+21%Q4'21$14.6B+6%Q1'22$15.4B+0%Q2'22$15.5B+11%Q3'22$17.2B+16%Q4'22$19.9B+15%Q1'23$22.8B
Activity profile
$ moved · Q1'23
New3%Increased77%Decreased18%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.1 years
<1Q4%1-4Q11%1-2Y7%2Y+78%

CAPTRUST FINANCIAL ADVISORS manages $22.8B across 2311 positions as of Q1 2023. Top holdings: IVV (3.8%), AAPL (3.7%), BIL (3.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 5/5.0.

Q1 2023 Summary

Active quarter - 380 new positions, 119 exits, 1055 increased. Top move: BIL (INCREASED, conviction 77). Portfolio: $22.8B across 2311 positions.

Top holdings by portfolio weight

Total AUM$23B
IVV3.77%
AAPL3.69%
BIL3.56%
VTV2.59%
MSFT2.26%
VEA1.72%
SPY1.71%
USMV1.64%
IBTD1.62%
IBTF1.62%
Other1.60%

Portfolio allocation by GICS sector

Sectors11
Unknown50.47%
Technology11.93%
Healthcare7.01%
Financial Services6.66%
Industrials5.08%
Consumer Cyclical4.62%
Consumer Defensive3.84%
Energy3.39%
Communication Services3.05%
Basic Materials1.62%
Other2.33%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Elite(5.0 / 5.0)
Track Record61
Conviction41
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ABBVABBVABBVIE INC
Q3 2024 Q2 2026+649,630 shares+$257M
8Q
BCIBCIABRDN ETFS
Q3 2024 Q2 2026+36,409 shares+$867,503
8Q
ADPTADPTAdaptive Biotechnologies Corp.
Q3 2024 Q2 2026+12,146 shares+$462,243
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used